Form 4: Oric Pharma Director Angie You Granted 40,000 Stock Options

Oric Pharmaceuticals director Angie You received a grant of 40,000 stock options with a strike price of $8.17, vesting monthly over one year.

Summary

• Angie You, a Director of Oric Pharmaceuticals, Inc. (ORIC), was granted 40,000 stock options.
• The options have an exercise price of $8.17 per share.
• The transaction date for this grant was January 2, 2026.
• The options will vest at a rate of 1/12th of the total shares on each one-month anniversary of January 2, 2026.
• The expiration date for these stock options is January 1, 2036.

Sentiment

Score: 6

Explanation: Slightly positive due to the alignment of director incentives with shareholder interests, though it's a routine compensation event with potential minor dilution.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, incentivizing long-term company performance.
• The vesting schedule encourages continued service and commitment from the director.

Negatives

• The issuance of new stock options could lead to potential future dilution for existing shareholders if exercised.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance beyond the vesting and expiration dates of the options.

Industry Context

This is a routine insider compensation report common across all industries, reflecting standard practices for incentivizing directors and executives with equity. It does not provide specific industry-related insights.

Stakeholder Impact

• Shareholders: Potential for minor dilution if options are exercised in the future, but also improved alignment of director incentives with shareholder value creation.
• Employees: No direct impact on general employees mentioned.

Next Steps

• The granted stock options will vest monthly, with 1/12th of the shares vesting on each one-month anniversary of January 2, 2026.

Key Dates

Keywords

Oric Pharmaceuticals, ORIC, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, Angie You